Esther P M Tjin

Author PubWeight™ 6.81^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	In vivo vitiligo induction and therapy model: double-blind, randomized clinical trial.	Pigment Cell Melanoma Res	2011	1.50
2	First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi.	Pigment Cell Melanoma Res	2010	0.96
3	The HGF/MET pathway as target for the treatment of multiple myeloma and B-cell lymphomas.	Biochim Biophys Acta	2010	0.94
4	c-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination.	J Immunol	2002	0.92
5	Effective melanoma immunotherapy in mice by the skin-depigmenting agent monobenzone and the adjuvants imiquimod and CpG.	PLoS One	2010	0.88
6	Melanocyte-specific immune response in a patient with multiple regressing nevi and a history of melanoma.	Anticancer Res	2011	0.83
7	The antibody response against MART-1 differs in patients with melanoma-associated leucoderma and vitiligo.	Pigment Cell Melanoma Res	2014	0.77